Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer

Title:	Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer
Authors:	Owen, Dwight H.^{Aff1, Aff2, IDs1063702501591y_cor1}; Wu, Ruohan^Aff1; Wei, Lai^Aff3; Dikov, Mikhail^Aff1; Suman, Shankar^{Aff1, Aff8}; Su, Po-Lan^{Aff1, Aff4}; Amann, Joseph^Aff1; Guan, Shuxiao^Aff1; Spakowicz, Daniel^{Aff1, Aff2}; Schweitzer, Catherine^Aff5; Pilcher, Carly^Aff5; Smith, Michael B.^Aff6; Ferguson, Sarah^Aff5; Palomino, Julio Castro^Aff7; Pérez, Santiago Figueroa^Aff7; Bertino, Erin M.^Aff1; Shields, Peter G.^{Aff1, Aff2}; He, Kai^{Aff1, Aff2}; Presley, Carolyn J.^Aff1; Otterson, Gregory A.^Aff1; Carson, William E.^{Aff1, Aff2}; Carbone, David P.^{Aff1, Aff2}
Source:	Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 43(6):1211-1221
Database:	Springer Nature Journals